An investor asked on the investor interaction platform: Hello, at present, yingkerui innovative medicine has received seven phases of listing counseling. How long will it be listed?
Shanghai Kaibao Pharmaceutical Co.Ltd(300039) ( Shanghai Kaibao Pharmaceutical Co.Ltd(300039) . SZ) said on the investor interaction platform on April 29 that the equity investment company, a wholly-owned subsidiary of the company, participated in Beijing yingkerui innovative pharmaceutical Co., Ltd. and the listing of yingkerui company is still in progress. Please pay attention to the official media, consult the official website of yingkerui company or contact yingkerui company for details. The company conscientiously performs the obligation of information disclosure of Listed Companies in strict accordance with the requirements of relevant laws and regulations.
